Comerica Bank
ALDX icon

Comerica Bank’s Aldeyra Therapeutics ALDX Stock Holding History

Comerica Bank’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-238
Closed -$1.37K – 3693
2025
Q1 		$1.37K Hold
238
– – ﹤0.01% 3530
2024
Q4 		$1.19K Hold
238
– – ﹤0.01% 3554
2024
Q3 		$1.28K Buy
238
+49
+26% +$233 ﹤0.01% 3551
2024
Q2 		$626 Hold
189
– – ﹤0.01% 3615
2024
Q1 		$618 Hold
189
– – ﹤0.01% 3663
2023
Q4 		$663 Buy
189
+114
+152% +$352 ﹤0.01% 3654
2023
Q3 		$501 Buy
+75
New +$556 ﹤0.01% 3711

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Comerica Bank's ALDX Position: Q2 2025 in Review

Comerica Bank sold out of Aldeyra Therapeutics (ALDX) in Q2 2025, closing a stake of 238 shares — an estimated $1.37K sold.

Comerica Bank first reported a position in ALDX in Q3 2023 and held it in 7 quarters. The position peaked at $1.37K in Q1 2025. 121 funds tracked by Wall St. Rank hold ALDX as of Q2 2025.

  • Comerica Bank reported no remaining Aldeyra Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 238 Aldeyra Therapeutics shares in Q2 2025, an estimated $1.37K.
  • Comerica Bank first reported a position in Aldeyra Therapeutics in Q3 2023 and held it in 7 quarters.
  • Comerica Bank's Aldeyra Therapeutics position peaked at $1.37K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.